Regulus Therapeutics Inc. - Common Stock, par value $0.001 per share (RGLS)

48 filings reported holding RGLS - Regulus Therapeutics Inc. - Common Stock, par value $0.001 per share as of Q1 2024.
Regulus Therapeutics Inc. - Common Stock, par value $0.001 per share (RGLS) has 44 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 45.6M shares of 66.5M outstanding shares and own 68.6% of the company stock.
Largest 10 shareholders include FEDERATED HERMES, INC. (12.9M shares), RA CAPITAL MANAGEMENT, L.P. (6.25M shares), Vivo Capital, LLC (5M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (3.68M shares), Deep Track Capital, LP (3.27M shares), FMR LLC (2.92M shares), MILLENNIUM MANAGEMENT LLC (1.88M shares), Soleus Capital Management, L.P. (1.56M shares), CVI Holdings, LLC (1.41M shares), and DAFNA Capital Management LLC (1.07M shares).
This table shows the top 44 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.